KRM Ayurveda IPO Listing at 27.48% Premium at ₹172.10 Per Share

KRM Ayurveda IPO listing delivers 27.48% discount at ₹172.10 per share over the issue price band of ₹128 to ₹135 per share. The KRM Ayurveda IPO was subscribed 74.27 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 63.31 times, and non-institutional investors (NIIs) received 135.37 times. The retail quota of the issue was subscribed to 31.57%. Before delving deeper into the topic, go through the details of the KRM Ayurveda IPO.

KRM Ayurveda IPO 

It is a book-building IPO of ₹77.49 crore, an entirely fresh issue of 0.57 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 29th January 2026. The KRM Ayurveda IPO date is scheduled from 21st January 2026 to 23rd January 2026. The face value of KRM Ayurveda shares stands at ₹10 per share, and the IPO Issue price band is set at ₹128 to ₹135 per share

KRM Ayurveda IPO Listing

On the NSE & SME platforms, KRM Ayurveda shares are listed at ₹172.10 per share, reflecting a 27.48% discount to the issue price of ₹135.00 per share. 

About the KRM Ayurveda IPO 

KRM Ayurveda Limited was established on 3 September 2019. KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and has also marked its presence abroad through telemedicine consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care/wellness-related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities:

• Beds, including general wards and premium rooms.
• Panchakarma treatment units.
• Herbal pharmacy and medicine preparation unit.
• Ayurvedic diet kitchen
• Consultation chambers for Vaidyas (Ayurvedic physicians).
• In-house yoga and meditation hall.

KRM Ayurveda Limited Financials

The company’s financial analysis is essential before applying for KRM Ayurveda Limited’s IPO. Refer to the table to learn about Vidya Wires Limited’s financial information. 

Explanation

KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

Recent Articles

Kasturi Metal Composite IPO GMP & Subscription Status: Day 2 IPO Live Updates

Accretion Nutraveda IPO GMP & Subscription Status: Day 1 IPO Live Updates

Msafe Equipments IPO GMP & Subscription Status: Day 1 IPO Live Updates

Kanishk Aluminium India IPO GMP & Subscription Status: Day 1 IPO Live Updates

Digilogic Systems IPO Listing at 20.00% discount at 83.20 Per Share

Shadowfax Technologies IPO Listing at 9.00% discount at 112.60 Per Share